Navigation Links
Nearly 25% of Women With Early Ovarian Cancer Not Given Recommended Biopsies
Date:2/10/2011

THURSDAY, Feb. 10 (HealthDay News) -- More than one-quarter of women with apparent early-stage ovarian cancer don't receive recommended lymph node biopsies to check for cancer spread, which nearly doubles these patients' risk of death, say U.S. researchers.

The team at the University of California Davis Cancer Center and California Cancer Registry analyzed the medical records and cancer registry data of 721 presumed early-stage ovarian cancer patients in California and New York and found that only 72 percent had lymph nodes from the pelvis and abdomen tested for signs of cancer spread.

The five-year survival rate was 84 percent for patients who had lymph node biopsies and 69 percent for those who did not have the biopsies.

The study also found that gynecologic oncologists were nearly 6.5 times more likely to perform lymph node biopsies than other surgical specialists, and nearly four times more likely to perform all recommended staging biopsies.

It's not clear why some surgeons do not remove lymph nodes during surgery for early-stage ovarian cancer, said senior author Dr. Gary Leiserowitz, chief of gynecologic oncology at the UC Davis Cancer Center, in a university news release. It may be that they don't believe the patient would benefit either because they're older or have other serious health problems, or both.

But unless a patient is clearly medically unsuited for the lifesaving biopsies, they should be done, study authors added.

The study appears online and in the April print issue of the journal Gynecological Oncology.

More information

The U.S. National Cancer Institute has more about ovarian cancer.

-- Robert Preidt

SOURCE: University of California, Davis, news release, Feb. 2, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Researchers predict nearly 1.3 million cancer deaths in Europe in 2011
2. Obesity Has Nearly Doubled Worldwide Since 1980: Report
3. Nearly Half of Americans Still Suspect Vaccine-Autism Link
4. Personalized vaccine for lymphoma patients extends disease-free survival by nearly 2 years
5. National Cancer Institute awards nearly $4 million to University of New Mexico Cancer Center
6. Healthy Living Can Prevent Nearly 25% of Colorectal Cancers
7. Nearly 1 in 5 W.Va. 5th Graders May Have High Blood Pressure
8. Scientists receive nearly $11 million to develop radiation countermeasures
9. Eye Disease Affects Nearly One in Three Diabetics
10. Nearly 1 in 5 Californians report need for mental health services, study finds
11. Susan G. Komen awards Case Western Reserve nearly $500,000 to study breast cancer in older women
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Nearly 25% of Women With Early Ovarian Cancer Not Given Recommended Biopsies
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized health ... expanded their existing home health joint venture through an agreement, effective October 1, ... joint venture home health company with Asante, delivering clinically integrated care, for the ...
(Date:10/12/2017)... ... , ... HMP , a leader in healthcare events and education, today announced ... Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie ... competition recognizes editorial and design excellence across a range of sectors. This year’s program ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
(Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis , ... supply chains, has published the first annual edition of its Global CSR ... than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed ... ... & Performance Index ...
Breaking Medicine Technology: